A solution to the dilution: The role for biomarkers in advanced ovarian cancer

Katelyn F. Handley; Anil K. Sood

doi:10.1158/1078-0432.CCR-19-3072

A solution to the dilution: The role for biomarkers in advanced ovarian cancer

Katelyn F. Handley, Anil K. Sood

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.

Original language	English (US)
Pages (from-to)	9-10
Number of pages	2
Journal	Clinical Cancer Research
Volume	26
Issue number	1
DOIs	https://doi.org/10.1158/1078-0432.CCR-19-3072
State	Published - Jan 1 2020

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-19-3072

Cite this

@article{b744d34787694fe68b6e91570590feb7,

title = "A solution to the dilution: The role for biomarkers in advanced ovarian cancer",

abstract = "Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.",

author = "Handley, {Katelyn F.} and Sood, {Anil K.}",

note = "Publisher Copyright: {\textcopyright}2019 American Association for Cancer Research.",

year = "2020",

month = jan,

day = "1",

doi = "10.1158/1078-0432.CCR-19-3072",

language = "English (US)",

volume = "26",

pages = "9--10",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

TY - JOUR

T1 - A solution to the dilution

T2 - The role for biomarkers in advanced ovarian cancer

AU - Handley, Katelyn F.

AU - Sood, Anil K.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.

AB - Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.

UR - http://www.scopus.com/inward/record.url?scp=85077476072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077476072&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-19-3072

DO - 10.1158/1078-0432.CCR-19-3072

M3 - Article

C2 - 31672769

AN - SCOPUS:85077476072

SN - 1078-0432

VL - 26

SP - 9

EP - 10

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 1

ER -

A solution to the dilution: The role for biomarkers in advanced ovarian cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this